NUWE — Nuwellis, Inc.

Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1506492 ·
Last close
$3.04
Market Cap
$280.3K
52W High
$44.80
52W Low
$2.75
ADV30
186,391
Next earnings
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 2,403,000 1,684,000 -4,568,000 -4,541,000 6,961,000 2,083,000 4,292,000
Dec 2025 2,424,000 1,654,000 -2,443,000 -2,422,000 6,118,000 1,085,000 3,488,000
Sep 2025 2,217,000 1,445,000 -2,697,000 468,000 7,984,000 3,094,000 4,070,000
Jun 2025 1,725,000 958,000 -2,906,000 -12,553,000 9,200,000 4,450,000 18,155,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-11,386,000
Investing CF
$-374,000
Financing CF
$11,335,000
CapEx
$-241,000
Dividends Paid
Buybacks
EPS Diluted TTM
$-64.00
As of
2026-06-07

Balance + Analyst (yfinance extras)

Retained Earnings
$-320,853,000
Inventory
$1,779,000
Receivables
$1,559,000
ST Investments
EBIT TTM
$-8,518,000
Pretax Income TTM
$-19,044,000
Interest Exp TTM
$10,553,000
Analysts

Yahoo Snapshot (yfinance, live)

Total Revenue
$8,769,000
EBITDA
$-12,449,000
Free Cash Flow
$-13,435,375
Enterprise Value
$-1,589,412
Total Cash
$2,083,000
Total Debt
$265,000
Shares Out
92,201
Trailing EPS
$-941.19
Book Value
$35.34
ROE
-609.4%
ROA
-112.9%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 8,270,000 -11,106,000 -17,521,000 6,118,000 3,488,000 -10,810,000
Dec 2024 8,740,000 -10,988,000 -11,165,000 9,864,000 3,334,000 -9,591,000
Dec 2023 8,864,000 -17,630,000 -20,209,000 9,770,000 6,559,000 -17,937,000
Dec 2022 8,543,000 -17,171,000 -14,525,000 24,673,000 12,316,000 -15,149,000

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$-2.59

Peers — same industry

TickerNameMarket CapLastDaily %
EMED Electromedical Technologies, Inc $373.2K $0.00
ENDV ENDONOVO THERAPEUTICS, INC. $180.8K $0.00
SSKN STRATA Skin Sciences, Inc. $529.9K $0.09
ODYY Odyssey Health, Inc. $706.8K $0.01
LGMK LogicMark, Inc. $899.8K $1.00

News headlines (Yahoo Finance, 1h cache)

Nuwellis to Showcase Aquadex Therapy at KidneyBee Summit 2026
2026-07-07 12:00 · Yahoo
Nuwellis Celebrates Five Years of Support of the Pediatric Cardiac Critical Care Consortium (PC⁴)
2026-06-26 12:00 · Yahoo
Nuwellis Announces Pediatric Expansion in Michigan with First Aquadex SmartFlow® Installations
2026-06-25 12:30 · Yahoo
Incoming Nuwellis CEO Mike McCormick Underscores Strategic Priorities for Continued Market Expansion in Pediatric Category and Revenue Generation in Letter to Shareholders
2026-06-24 12:30 · Yahoo
Nuwellis Expands Critical Care Education with Aquadex Training at University of Minnesota Critical Care Cardiology Education Summit
2026-06-18 12:30 · Yahoo
Nuwellis Appoints Mike McCormick as Chief Executive Officer
2026-06-16 12:30 · Yahoo
Nuwellis Expands Collaboration with Major South Carolina Healthcare System to Install New Aquadex SmartFlow® Devices at One of its Children’s Hospitals
2026-06-10 12:30 · Yahoo
Nuwellis Announces Closing of $6.0 Million Registered Public Offering
2026-06-09 01:46 · Yahoo
Nuwellis Shares Sink After Pricing $6 Million Equity and Warrant Offering (NUWE)
2026-06-05 14:29 · Yahoo
Nuwellis Announces Pricing of $6 Million Public Offering
2026-06-05 12:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.